№ files_lp_4_process_3_095681
File format: docx Character count: 24041 File size: 310 KB
Comprehensive supplemental tables reporting patient characteristics, treatment regimens, and CRT recommendations based on Swedish national registries for heart failure patients.
Year: 2008-2021
Region: Sweden
Topic: Heart failure management and cardiac resynchronization therapy
Document type: Supplemental material / Research tables
Organization: European Society of Cardiology, SwedeHF, NPR, NPDR
Authors: Not specified
Target audience: Cardiologists, researchers, clinicians in cardiology
Data sources: SwedeHF, National Patient Register (NPR), National Prescribed Drug Registry (NPDR), ICD & PM Registry, LISA, RTP
Variables: Demographics, clinical parameters, comorbidities, treatment, socioeconomics
Methodology: Data extraction from registries, calculation of target doses, follow-up analysis
Limitations: Missing data in some variables, assumptions for combination drug dosing
Guideline period: 2008-2021 ESC HF guidelines
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Guideline-Directed Medical Therapy in Heart Failure (6.16.25) August 4, 2025 – December 31, 2025
Year: 2025
Region / city: California
Topic: Medical education, Heart failure treatment
Document type: Educational guideline
Institution: University of California, Irvine School of Medicine
Author: University of California, Irvine School of Medicine
Target audience: Specialties – Emergency Medicine, Family Medicine, Medicine, Neurology, Obstetrics & Gynecology, Radiological Sciences, Other
Period of validity: August 4, 2025 – December 31, 2025
Approval date: Not specified
Date of changes: Not specified
Supplemental Data Tables on R406 Solubility in Buffers and In Vitro Pharmacological Profile
Document type: Supplemental data tables
Subject: R406 solubility and in vitro pharmacological profiling
Compound: R406
Experimental context: Pharmacological profiling experiments
Assay types: Radioligand binding assays; isolated enzyme activity assays
Measured parameters: Solubility (µM); pIC50; pKi
Timepoints: 3 hour; 24 hour
Solvent conditions: 0.1%, 0.3%, and 1% DMSO
Buffer systems: Non-kinase buffers; kinase binding buffer; isolated kinase buffers; phosphate-buffered saline
Target scope: Non-kinase targets across enzyme, receptor, ion channel, and transporter classes
Definitions provided: Inactivity threshold defined as pIC50 of 3.5 (<50% inhibition at 10 µM or non-reproducible activity)
Supplementary Materials for a Comprehensive Review on the Chemical Properties, Plant Sources, Pharmacological Activities, Pharmacokinetic and Toxicological Characteristics of Tetrahydropalmatine
Year: 2021
Region / City: China and Southeast Asia
Subject: Pharmacology, Ethnobotany, Phytochemistry
Document Type: Supplementary material / Scientific review data
Institution: Chengdu University of Traditional Chinese Medicine
Authors: Qinyun Du, Xianli Meng, Shaohui Wang
Target Audience: Researchers and professionals in pharmacology and traditional medicine
Data Coverage: Plant species, pharmacological activities, extraction methods, and chemical properties
Date of Publication: 2021
References Included: Yes, multiple sources cited for plant species and pharmacological effects
Language: English
Document Structure: Tables with plant sources, pharmacological actions, and extraction methods
Kasni (Cichorium intybus Linn.): A Scientific Overview of Traditional and Pharmacological Uses
Year: 2026
Region / city: Global
Subject: Medicinal plants, Traditional medicine, Pharmacology
Document type: Review article
Institution / organization: Unani medicine research institutions
Author: Not specified
Target audience: Researchers, healthcare professionals, students of traditional medicine
Plant profile: Cichorium intybus Linn., including leaves, roots, flowers, and seeds
Pharmacological properties: Hypoglycemic, hypolipidemic, hepatoprotective, gastroprotective, anti-inflammatory, analgesic, antioxidant, antiallergic, antimicrobial
Traditional uses: Liver tonic, digestive aid, deobstruent, blood purifier, mild laxative
Geographical distribution: India, Europe, West Asia, South Africa
Varieties: Bustani (cultivated), Dashti (wild)
Botanical classification: Kingdom Plantae, Family Asteraceae, Genus Cichorium
Keywords: Kasni, Chicory, Coffee substitute, Unani, Therapeutic action, Traditional use
Supplementary Table 1. Search Strategy for Crohn Disease and Pharmacological Interventions (2020–Current)
Document type: Supplementary table
Subject: Crohn disease pharmacological treatment search strategy
Topic: Literature search methodology for inflammatory bowel disease therapies
Disease focus: Crohn disease
Interventions: Tumor necrosis factor inhibitors, monoclonal antibodies, JAK inhibitors, cytokine inhibitors, immunomodulators, aminosalicylates, methotrexate, azathioprine, mercaptopurine
Data sources: MEDLINE, Cochrane Central Register of Controlled Trials (CCTR), Embase
Search fields: Title, abstract, keywords, registry numbers
Search period: 2020–Current
Methodology: Structured database search strategy using controlled vocabulary and keyword combinations
Research context: Identification of studies on pharmacological treatments for Crohn disease
Postdoctoral Fellowship Competition in Chemical, Pharmacological, and Bioengineering Fields
Year: 2017
Region / City: New Jersey
Topic: Postdoctoral Fellowship
Document Type: Announcement
Organization: New Jersey Institute of Technology
Author: Not specified
Target Audience: Young scientists with a PhD
Effective Period: N/A
Approval Date: N/A
Amendment Date: N/A
Topics: resynchronization Guideline-Directed Pharmacological